Skip to main content
logo
Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.160
-0.020 (-1.69%)
At close: Sep 15, 2026, 4:00 PM EDT
1.141
-0.019 (-1.60%)
After-hours: Sep 15, 2026, 4:22 PM EDT

Inovio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
120120661393891,050
Market Cap Growth
-5.18%80.95%-52.55%-64.23%-62.93%-29.98%
Enterprise Value
9179-62140688
Last Close Price
1.181.741.836.1218.7259.88

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1829.48303.38167.3337.93591.53
PB Ratio
22.234.960.961.191.752.63
P/TBV Ratio
27.794.960.961.191.862.72

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-1205.35-1.8613.62387.68

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.830.390.170.260.140.08
Net Debt / Equity Ratio
-6.56-2.04-1.20-0.98-0.99-0.92
Net Debt / EBITDA Ratio
0.370.570.740.930.891.24
Net Debt / FCF Ratio
0.360.550.790.921.021.70
Asset Turnover
-0.000.000.000.020.00
Quick Ratio
0.921.342.703.472.736.23
Current Ratio
1.001.402.773.603.256.82
Return on Equity (ROE)
-409.87%-183.47%-115.42%-79.55%-89.97%-70.55%
Return on Assets (ROA)
-84.23%-57.88%-49.45%-30.50%-37.53%-36.35%
Return on Capital Employed (ROCE)
-836.60%-283.30%-144.30%-98.70%-100.80%-70.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-55.50%-71.06%-162.35%-97.05%-71.89%-28.93%
FCF Yield
-66.49%-74.38%-158.28%-89.56%-55.80%-20.66%
Buyback Yield / Dilution
-92.40%-72.63%-22.49%-11.51%-14.27%-34.62%
SEC Filings: 10-K · 10-Q